Ledger.Open graph →
SEC Form D · filed March 12, 2025

Vivace Therapeutics, Inc

Offering
$35.0M
Sold
$17.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Mateo, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Edward Hu · Orinda, CADirectorJun Wu · San Mateo, CADirectorJake Simson · Cambridge, MADirectorTim Shannon · Westport, CTDirectorChenguang Zhou · San Mateo, CADirectorShuang Qiao · San Bruno, CAExec · DirectorEdward Hu · Orinda, CADirectorJun Wu · San Mateo, CADirectorJake Simson · Cambridge, MADirectorTim Shannon · Orinda, CADirectorChenguang Zhou · San Mateo, CADirectorShuang Qiao · Orinda, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗